109060 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof; DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
CHIMERIC PROTEINS COMPRISING MEMBRANE BOUND IL-12 WITH PROTEASE CLEAVABLE LINKERS
#2IMMUNE CELL HAVING MEMBRANE-BOUND IL-21, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#3CHIMERIC ANTIGEN RECEPTOR SPECIFIC TO CD117
#4NOVEL CD200 FUSION PROTEINS
#5Polyamine Reporters
#6METHODS FOR REPROGRAMMING AND GENE EDITING CELLS
#7POLYNUCLEOTIDES AND LENTIVIRAL VECTORS EXPRESSING NON-STRUCTURAL ANTIGENS OF A FLAVIVIRUS SELECTED FROM THE GROUP OF DENV, ZIKV AND YFV, INDUCING PROTECTIVE CD8+ T-CELL IMMUNITY IN A HOST
#8PRODUCTION OF PROTEINS, INCLUDING SECRETED PROTEINS
#9CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELL THAT TARGETS EGFR
#10ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR DELTA-LIKE LIGAND 3 (DLL3)
#11CLL-1 TARGETED IMMUNOTHERAPIES
#12BIOORTHOGONAL T CELL RECEPTOR MOLECULES AND METHODS OF MAKING AND USING THE SAME
#13Modified Cytotoxic T Cells and Methods of Use Thereof
#14MEMBRANE-ANCHORED CYTOKINES, ENGINEERED IMMUNE CELLS, AND USES THEREOF
#15NPP1 Fusion Proteins
#16FUSION POLYPEPTIDES FOR CELL PENETRATION AND CELL TARGETING
#17Pocket Engineering of HLA Alleles for Treating Autoimmunity
#18Immune Cells Comprising Truncated NKG2D Chimeric Receptors
#19SYNTHETIC PRE-PROTEIN SIGNAL PEPTIDES FOR DIRECTING SECRETION OF HETEROLOGOUS PROTEINS IN ESCHERICHIA BACTERIA
#20GENE THERAPY FOR AADC DEFICIENCY
#21TARGETED PROTEIN DEGRADATION SYSTEM AND USE THEREOF
#22USE OF CD8-TARGETED VIRAL VECTORS
#23METHOD FOR PRODUCING A PERIPLASMIC FORM OF THE PROTEIN CRM197
#24COMPOSITIONS AND METHODS FOR MYOSIN HEAVY CHAIN BASE EDITING
#25Compositions for Treating Pathological Calcification Conditions, and Methods Using Same
#26COMPOSITIONS AND METHODS FOR PROMOTING HOMOLOGY DIRECTED REPAIR
#27MODIFIED STRAINS FOR IMPROVED SECRETION OF RECOMBINANT PROTEINS
#28METHODS AND COMPOSITIONS FOR CELLULAR THERAPY
#29ONCOLYTIC HERPES SIMPLEX VIRUS VECTORS EXPRESSING IMMUNE SYSTEM-STIMULATORY MOLECULES
#30SYNCITIN-1 FUSION PROTEINS AND USES THEREOF FOR CARGO DELIVERY INTO TARGET CELLS
#31HLA ENGINEERING METHODS AND COMPOSITIONS FOR TREATMENT OF AUTOIMMUNITY
#32BINDING FUSION PROTEINS, BINDING FUSION PROTEIN-DRUG CONJUGATES, XTEN-DRUG CONJUGATES AND METHODS OF MAKING AND USING SAME
#33TYPE II CAS PROTEINS AND APPLICATIONS THEREOF
#34EFFICIENT TCR GENE EDITING IN T LYMPHOCYTES
#35SYSTEMS, APPARATUSES, AND METHODS FOR CELLULAR THERAPEUTICS MANUFACTURE
#36COMPOSITIONS AND METHODS FOR PREVENTION OF PISCINE MYOCARDITIS
#37COMPOSITIONS AND METHODS FOR PRODUCING HIGH SECRETED YIELDS OF RECOMBINANT PROTEINS
#38EXPRESSION IN MAMMALIAN CELLS WITH SIGNAL PEPTIDE
#39PRODUCTS AND METHODS FOR HETEROLOGOUS EXPRESSION OF PROTEINS IN A HOST CELL
#40DNA VECTORS, TRANSPOSONS AND TRANSPOSASES FOR EUKARYOTIC GENOME MODIFICATION
#41SYNTHETICALLY EVOLVED DNA CONSTRUCTS FOR REGULATING SIGNAL PEPTIDE PERFORMANCE AS WELL AS VECTORS, HOST CELLS AND RECOMBINANT PROTEINS THEREOF
#42NOVEL LUCIFERASES AND METHODS FOR USING SAME
#43LEADER PEPTIDES AND POLYNUCLEOTIDES ENCODING THE SAME
#44INTERGENERIC ENDOSPORE DISPLAY PLATFORMS, PRODUCTS AND METHODS
#45OPTOGENETIC VISUAL RESTORATION USING CHRIMSON
#46SIGNAL PEPTIDES FOR INCREASED PROTEIN SECRETION
#47Compositions and Methods for Treating Hereditary Angioedema
#48GENE THERAPY FOR AADC DEFICIENCY
#49Oncolytic viruses targeting STAT3
#50SYNOVIAL EXTRACELLULAR MATRIX-SPECIFIC CHIMERIC ANTIGEN RECEPTOR FOR TARGETING REGULATORY T CELLS TO TREAT AUTOIMMUNE DISEASES
#51Modified strains for improved secretion of recombinant proteins
#52COMPOSITIONS AND METHODS FOR PRODUCING POLYPEPTIDES WITH A MODIFIED GLYCOSYLATION PATTERN IN PLANT CELLS
#53COMPOSITIONS AND METHODS FOR INDUCIBLE ALTERNATIVE SPLICING REGULATION OF GENE EXPRESSION
#54Fusion protein and use thereof in base editing
#55Enzymes for Sialylation of Glycans
#56Pocket Engineering of HLA Alleles for Treating Autoimmunity
#57PLANT TRANSACTIVATION INTERACTION MOTIFS AND USES THEREOF
#58FLAVIVIRUS SIGNAL PEPTIDES, VACCINE CONSTRUCTS, AND METHODS THEREFOR
#59REAL-TIME CELLULAR THERMAL SHIFT ASSAY (RT-CETSA) FOR RESEARCH AND DRUG DISCOVERY
#60LIGHT-INDUCIBLE GENE ACTIVATION SYSTEMS AND METHODS FOR MAKING AND USING THEM
#61YEAST DISPLAY LIBRARIES, ASSOCIATED COMPOSITIONS, AND ASSOCIATE METHODS OF USE
#62FUSION PROTEIN FOR REVERSING TUMOR MICROENVIRONMENT AND USE THEREOF
#63FUSION POLYPEPTIDES FOR TARGET PEPTIDE PRODUCTION
#64HLA engineering methods and compositions for treatment of autoimmunity
#65FUSION PROTEINS AND METHODS OF USE THEREOF
#66COMPOSITIONS AND METHODS FOR SEQUENTIAL STACKING OF NUCLEIC ACID SEQUENCES INTO A GENOMIC LOCUS
#67PLASMID ENCODING B-CELL ACTIVATING FACTOR RECEPTOR (BAFF-R) AND USES OF SAME IN THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES IN FISH
#68NPP1 FUSION PROTEINS
#69ANTI-GLYCO-CD44 ANTIBODIES AND THEIR USES
#70ENHANCED EXPRESSION YIELD OF IMMUNOGLOBULIN A IN EUKARYOTES
#71ULTRASONIC GENETICALLY ENCODED CALCIUM INDICATORS
#72PHOTORESPONSIVE PROTEIN FOR COLOR RECOGNITION AND USE THEREOF
#73INTEGRATION OF NUCLEIC ACID CONSTRUCTS INTO EUKARYOTIC CELLS WITH A TRANSPOSASE FROM ORYZIAS
#74ANAPLASTIC LYMPHOMA KINASE CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE
#75Lymphocyte Population and Methods for Producing Same
#76GENETICALLY-TARGETED CHEMICAL ASSEMBLY: BUILDING FUNCTIONAL STRUCTURES AND MATERIALS IN LIVING CELLS, TISSUES, AND ANIMALS
#77Pocket Engineering of HLA Alleles for Treating Autoimmunity
#78RNA-GUIDED GENOME RECOMBINEERING AT KILOBASE SCALE
#79LARGE GENE VECTORS AND DELIVERY AND USES THEREOF
#80METHODS FOR T CELL TRANSDUCTION
#81Chimeric Antigen Receptors Comprising Interleukin-9 Receptor Signaling Domain
#82POLYNUCLEOTIDES FOR DISRUPTING IMMUNE CELL ACTIVITY AND METHODS OF USE THEREOF
#83METHOD FOR IMPROVING ANTIGEN IMMUNOGENICITY, CORONAVIRUS ANTIGEN, USE THEREOF, RECOMBINANT VECTOR, EXPRESSION KIT, TRANSGENIC CELL LINE, RECOMBINANT BACTERIUM, CORONAVIRUS VACCINE, PREPARATION METHOD OF ANTIGEN AND NUCLEOTIDE SEQUENCE
#84Synovial extracellular matrix-specific chimeric antigen receptor for targeting regulatory T cells to treat autoimmune diseases
#85ANTI-MUC1 COMPOSITIONS AND METHODS OF USE
#86Targeted Translation of RNA with CRISPR-Cas13 to Enhance Protein Synthesis
#87IN-SERIES SYNTHETIC RECEPTOR AND-GATE CIRCUITS FOR EXPRESSION OF A THERAPEUTIC PAYLOAD BY ENGINEERED CELLS
#88CELL-TO-CELL DELIVERY OF RNA CIRCUITS
#89CHIMERIC ANTIGEN RECEPTORS TO HER2 AND METHODS OF USE THEREOF
#90CHIMERIC ANTIGEN RECEPTORS, VECTORS CODING FOR SUCH RECEPTORS AND THEIR USE IN THE MODIFICATION OF T CELLS
#91CANCER GENE THERAPY DRUG
#92IMPROVED VARIANTS OF TEV PROTEASE FOR BIOTECHNOLOGICAL APPLICATIONS
#93SAFETY SWITCHES FOR REGULATION OF GENE EXPRESSION
#94Dimeric Antigen Receptors (DAR) That Bind CD20
#95BINDING FUSION PROTEINS, BINDING FUSION PROTEIN-DRUG CONJUGATES, XTEN-DRUG CONJUGATES AND METHODS OF MAKING AND USING SAME
#96PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA (PRAME) T CELL RECEPTORS AND METHODS OF USE THEREOF
#97ENGINEERED IMMUNE KILLER CELL, PREPARATION METHOD THEREFOR AND USE THEREOF
#98CELLS EXPRESSING C-KIT MUTATIONS AND USES THEREOF
#99ANTIBODIES AGAINST LIF AND USES THEREOF
#100Adeno-Associated Viral (AAV) Vectors for Tissue-Targeted Expression of Therapeutic Genes
#101METHODS FOR MANUFACTURING GENETICALLY ENGINEERED CAR-T CELLS
#102Lymphocytes-antigen presenting cells co-stimulators and uses thereof
#103Efficient TCR gene editing in T lymphocytes
#104COMPOSITIONS AND METHODS FOR EPITOPE SCANNING
#105SPLIT DEAMINASE BASE EDITORS
#106SHARED NEOANTIGEN VACCINES
#107ENGINEERED CELLS WITH IMPROVED PROTECTION FROM NATURAL KILLER CELL KILLING
#108GENETICALLY MODIFIED PHOTOTROPHIC CELL FOR IN-VIVO PRODUCTION OF HYDROGEN
#109TRUNCATED NKG2D CHIMERIC RECEPTORS AND USES THEREOF IN NATURAL KILLER CELL IMMUNOTHERAPY
#110Receptors providing targeted costimulation for adoptive cell therapy
#111T-CELL MASTER CELL BANK
#112MODIFIED CYTOTOXIC T CELLS AND METHODS OF USE THEREOF
#113CHIMERIC TRANSCRIPTION FACTOR VARIANTS WITH AUGMENTED SENSITIVITY TO DRUG LIGAND INDUCTION OF TRANSGENE EXPRESSION IN MAMMALIAN CELLS
#114REAL-TIME G-PROTEIN COUPLED RECEPTOR (GPCR) LINKED BIOLUMINESCENT SENSING OF BIOLOGICAL TARGETS AND PROCESSES
#115CHIMERIC RECEPTOR PROTEINS AND USES THEREOF
#116LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING OF T CELLS
#117METHOD FOR PRODUCING NUCLEIC ACID MOLECULE, BIOMATERIAL, AND METHOD FOR PRODUCING BIOMATERIAL
#118UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION
#119COMPOSITIONS AND METHODS FOR IDENTIFYING MHC-II BINDING PEPTIDES
#120GENETICALLY ENGINEERED IMMUNE CELLS TARGETING CD70 FOR USE IN TREATING SOLID TUMORS
#121COMPOSITIONS AND METHODS FOR PROMOTING HEMATOPOIETIC CELL CYTOTOXICITY
#122ENGINEERED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF
#123siRNA EXPRESSION VECTOR
#124Base editing tool and use thereof
#125CRISPR TYPE V-U1 SYSTEM FROM MYCOBACTERIUM MUCOGENICUM AND USES THEREOF
#126ALLOGENEIC CELL COMPOSITIONS AND METHODS OF USE
#127GENERATION OF CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FROM STEM CELLS AND THERAPEUTIC USES THEREOF
#128SGRNA GUIDING PD1 GENE FOR CLEAVAGE TO ACHIEVE EFFICIENT INTEGRATION OF EXOGENOUS SEQUENCES
#129CELL FOR RESISTING TRANSPLANT REACTION AND METHOD
#130CHIMERIC ANTIGEN RECEPTOR TARGETING CLL1 AND USE THEREOF
#131IL-15 HUMANIZED MOUSE MODEL AND USE THEREOF
#132RECEPTORS PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY
#133Recombinant CD1-Restricted T Cells And Methods
#134VIRAL TARGETING OF HEMATOPOIETIC STEM CELLS
#135KRAS VARIANT MRNA MOLECULES
#136TREATMENT OF CELIAC DISEASE
#137MR1 RESTRICTED T CELL RECEPTORS FOR CANCER IMMUNOTHERAPY
#138CA2-IL15 FUSION PROTEINS FOR TUNABLE REGULATION
#139METHODS OF B CELL EXPANSION FOR USE IN CELL THERAPY
#140GENE TRANSFER VECTORS AND METHODS OF ENGINEERING CELLS
#141TRANSDUCTION EFFICIENCY ASSAY
#142BIOSYNTHESIS OF ALPHA-IONONE AND BETA-IONONE
#143IMMUNE EFFECTOR CELL FOR CO-EXPRESSING CHEMOKINE RECEPTOR
#144SYSTEMS, APPARATUSES, AND METHODS FOR CELLULAR THERAPEUTICS MANUFACTURE
#145MULTISPECIFIC TRANSTHYRETIN IMMUNOGLOBULIN FUSIONS
#146CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND CHIMERIC STIMULATING RECEPTORS AND USES THEREOF
#147CLL-1 TARGETED IMMUNOTHERAPIES
#148Method for Transduction of T Cells in the Presence of Malignant Cells
#149Chimeric protein and related genic transfer technology
#150NEF-CONTAINING T CELLS AND METHODS OF PRODUCING THEREOF
#151FUSION PROTEINS FOR IMPROVED ENZYME EXPRESSION
#152Compositions and methods for producing high secreted yields of recombinant proteins
#153AAV-ZYME AND USE FOR INFUSION REPLACEMENT THERAPY
#154SELECTIVE DEGRADATION OF PROTEINS
#155SYNTHETIC PLASMID DNA VACCINE EXPRESSING A CODON-OPTIMIZED SARS-COV-2 SPIKE PROTEIN AND METHODS FOR ITS USE
#156Synthetic plasmid DNA vaccine expressing a codon-optimized SARS-COV-2 spike protein
#157PROGRAMMABLE DNA BASE EDITING BY NME2CAS9-DEAMINASE FUSION PROTEINS
#158ANTI-CD83 CHIMERIC ANTIGEN RECEPTOR EXPRESSING T REGULATORY CELLS
#159Endotoxin-free Production of Recombinant Subunit Vaccine Components
#160DNA VECTORS, TRANSPOSONS AND TRANSPOSASES FOR EUKARYOTIC GENOME MODIFICATION
#161UBIQUITINATION-LACKING CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF
#162METHOD FOR MANUFACTURING MONOCLONAL ANTIBODY USING YEAST, AND SCREENING METHOD
#163Membrane Transport Protein and Uses Thereof
#164LENTIVIRAL TRANSDUCTION METHODS
#165GENETICALLY MODIFIED NK CELLS AND USES THEREOF
#166POPULATIONS OF NATURAL KILLER CELLS COMPRISING A CD38 CHIMERIC ANTIGEN RECEPTOR
#167COMPOSITIONS AND METHODS FOR SEQUENTIAL STACKING OF NUCLEIC ACID SEQUENCES INTO A GENOMIC LOCUS
#168CD79-specific chimeric antigen receptor
#169YEAST EXPRESSING THERMOSTABLE ALPHA-AMYLASES FOR HYDROLYSIS OF STARCH
#170ENGINEERED IMMUNE CELLS COMPRISING A RECOGNITION MOLECULE
#171ENGINEERED CELLS AND USES THEREOF
#172Modified Cell Expansion and Uses Thereof
#173ENGINEERED OFF-THE-SHELF IMMUNE CELLS AND METHODS OF USE THEREOF
#174Modulation of Engineered Immune Cell Receptor Translation Using Noncoding Sequence Elements
#175METHODS FOR PRODUCING CELL POPULATIONS WITH INCREASED NUCLEIC ACID UPTAKE
#176VIRUS-LIKE PARTICLE
#177CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS TARGETING ALK
#178ALLOGENEIC CELL THERAPY OF B CELL MALIGNANCIES USING GENETICALLY ENGINEERED T CELLS TARGETING CD19
#179USE OF CD8-TARGETED VIRAL VECTORS
#180UNSPECIFIC PEROXYGENASE ENZYME VARIANTS FOR SELECTIVE FATTY ACID EPOXIDATION OR HYDROXYLATION
#181AUTOMATED T CELL CULTURE
#182EXPRESSION CONSTRUCTS FOR THE GENETIC MODIFICATION OF CELLS
#183Method for Generation of Genetically Modified T Cells
#184LOCKR-MEDIATED RECRUITMENT OF CAR T CELLS
#185CELLS EXPRESSING A CHIMERIC RECEPTOR FROM A MODIFIED CD247 LOCUS, RELATED POLYNUCLEOTIDES AND METHODS
#186GENOMIC SAFE HARBORS FOR TRANSGENE INTEGRATION
#187ENGINEERED GAMMA DELTA T CELLS AND METHODS OF MAKING AND USING THEREOF
#188METHODS OF PREPARING POPULATIONS OF GENETICALLY-MODIFIED IMMUNE CELLS
#189COMBINATORIAL CAR T CELL AND HEMATOPOEITIC STEM CELL GENETIC ENGINEERING FOR SPECIFIC IMMUNOTHERAPY OF MYELOID LEUKEMIAS
#190COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASE
#191Diplospory gene
#192Enveloped Virus Resistant to Complement Inactivation for the Treatment of Cancer
#193High-Affinity TCR for Recognizing AFP Antigen
#194METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS
#195NUCLEIC ACID CONSTRUCT ENCODING Trk FRAGMENT AND USE THEREOF
#196Compositions for treating pathological calcification conditions, and methods using same
#197ONCOLYTIC VIRUSES TARGETING STAT3
#198ONCOLYTIC VIRUSES TARGETING STAT3
#199IMMUNE EFFECTOR CELL AND USE THEREOF
#200Combination of an immune checkpoint modulator and a complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist for use in medicine
#201COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS
#202Tandem Protein Expression
#203Compositions and methods for promoting homology directed repair
#204DECORATED INCLUSION BODY AND USES THEREOF
#205IMMUNE CELL FUNCTION
#206ENGINEERED EXTRACELLULAR VESICLES AND USES THEREOF
#207CELL LINES EXPRESSING INSERTED SECRETABLE REPORTER GENES AT MULTIPLE STAGES OF DIFFERENTIATION
#208ENDOSPORE DISPLAY PLATFORMS, PRODUCTS AND METHODS
#209RNA ENCODING A PROTEIN
#210MUTANT VACCINIA VIRUSES AND USE THEREOF
#211QUADRICISTRONIC SYSTEM COMPRISING A HOMING RECEPTOR AND CHIMERIC ANTIGEN RECEPTOR FOR STABLE GENETIC MODIFICATION OF CELLULAR IMMUNOTHERAPIES
#212A Method to Specifically Stimulate Survival and Expansion of Genetically-Modified Immune Cells
#213NPP1 FUSION PROTEINS
#214Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias
#215Virus-like particles and use thereof
#216-based endospore display platform, products and methods
#217Chimeric antigen receptor (CAR) and T cell receptor (TCR) modified T cells
#218Gene therapy for AADC deficiency
#219Compositions and methods for producing high secreted yields of recombinant proteins
#220Production method for protease of M23A subfamily
#221BINDING FUSION PROTEINS, BINDING FUSION PROTEIN-DRUG CONJUGATES, XTEN-DRUG CONJUGATES AND METHODS OF MAKING AND USING SAME
#222NUCLEIC ACID FOR TREATING CRUSTACEAN ALLERGY
#223SOLUBILITY ENHANCING PROTEIN EXPRESSION SYSTEMS
#224DNA vectors, transposons and transposases for eukaryotic genome modification
#225Method for producing nucleic acid molecule, biomaterial, and method for producing biomaterial
#226Plant transactivation interaction motifs and uses thereof
#227Luciferases and methods for using same
#228NON-HUMAN ANIMALS HAVING A HEXANUCLEOTIDE REPEAT EXPANSION IN A C9ORF72 LOCUS
#229Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias
#230M971 chimeric antigen receptors
#231Methods for treating pseudoxanthoma elasticum (PXE)
#232Recombinant PETase producing strain, recombinant MHETase producing strain, and composition for degrading PET containing the same
#233DNA vectors, transposons and transposases for eukaryotic genome modification
#234Methods and compositions for secretion of heterologous polypeptides
#235Chimeric transcription factor variants with augmented sensitivity to drug ligand induction of transgene expression in mammalian cells
#236SYNTHETIC HYBRID RECEPTOR AND GENETIC CIRCUIT IN BACTERIA TO DETECT ENTERIC PATHOGENIC MICROORGANISMS
#237Compositions and methods of use for treating metabolic disorders
#238Compositions for treating pathological calcification conditions, and methods using same
#239Truncated NKG2D chimeric receptors and uses thereof in natural killer cell immunotherapy
#240Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies
#241Expression vectors with promoter and nucleic acid
#242Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies
#243CANCER STEM CELL EXOSOMES
#244Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies
#245HYBRID IMMUNOGLOBULINS WITH MOVING PARTS
#246SEC modified strains for improved secretion of recombinant proteins
#247Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells
#248Method of increasing resistance to a fungal pathogen by applying a hydrophobin to a plant
#249Plant transactivation interaction motifs and uses thereof
#250Microorganism for delivering drug for treatment of gastrointestinal disease, which expresses and secretes P8 protein, and pharmaceutical composition for preventing or treating gastrointestinal disease, which includes the same
#251DNA Vectors, Transposons And Transposases For Eukaryotic Genome Modification
#252Fusion proteins comprising a non-cytotoxic protease, a translocation domain, and a targeting moiety that binds a galanin receptor and methods for treating, preventing or ameliorating pain using such fusion proteins
#253Signal Polypeptide For Improved Secretion Of Protein
#254RECOMBINANT NEL-LIKE (MELL) PROTEIN PRODUCTION
#255Compositions for treating pathological calcification conditions, and methods using same
#256Enveloped virus resistant to complement inactivation for the treatment of cancer
#257COMBINATION OF AN IMMUNE CHECKPOINT MODULATOR AND A COMPLEX COMPRISING A CELL PENETRATING PEPTIDE, A CARGO AND A TLR PEPTIDE AGONIST FOR USE IN MEDICINE
#258DNA Vectors, Transposons And Transposases For Eukaryotic Genome Modification
#259Oncolytic herpes simplex virus vectors expressing immune system-stimulatory molecules
#260AMPLIFIED PRODUCTION OF MONOCLONAL ANTIBODIES
#261FIBROBLAST GROWTH FACTOR (FGF) 1 PROTEINS WITH GLUCOSE LOWERING ABILITY AND REDUCED MITOGENICITY
#262Paenibacillus-based endospore display platform, products and methods
#263Generating targeted sequence diversity in fusion proteins
#264Oncolytic viruses targeting STAT3
#265Chimeric antigen receptor (CAR) and T cell receptor (TCR) modified T cells
#266COMPOSITION FOR SOLUBILIZING TARGET PROTEIN AND USE THEREOF
#267M971 chimeric antigen receptors
#268Synthetic promoters and uses thereof
#269Monoclonal antibody FnAb8 and application thereof
#270ENDOPLASMIC RETICULUM LOCALIZATION SIGNALS
#271DNA VECTORS, TRANSPOSONS AND TRANSPOSASES FOR EUKARYOTIC GENOME MODIFICATION
#272Gene therapy for AADC deficiency
#273Expression system for eukaryotic organisms
#274Chimeric antigen receptor targeting human NKG2DL and methods of preparing said receptor and pharmaceutical composition
#275Binding fusion proteins, binding fusion protein-drug conjugates, XTEN-drug conjugates and methods of making and using same
#276Synthetic hybrid receptor and genetic circuit in bacteria to detect enteric pathogenic microorganisms
#277Methods and compositions for modulating AAV infection
#278Expression in mammalian cells with Gaussia luciferase signal peptide
#279Mesenchymal stem cell-derived exosomes and their uses
#280Ubiquitin interacting motif peptides as therapeutics
#281DNA vectors, transposons and transposases for eukaryotic genome modification
#282COMPOSITIONS AND METHODS FOR PROMOTING HOMOLOGY DIRECTED REPAIR
#283Diplospory gene
#284THERAPEUTIC VACCINE FOR TREATING OR PREVENTING MERKEL CELL POLYOMA VIRUS-ASSOCIATED TUMORS
#285Slit2D2-HSA fusion protein and use thereof against tumours
#286MicroRNA initiated DNAzyme motor operating in living cells
#287Generating targeted sequence diversity in fusion proteins
#288Non-human animals having a hexanucleotide repeat expansion in a C9ORF72 locus
#289Expression vectors with promoter and nucleic acid
#290Compositions for treating pathological calcification conditions, and methods using same
#291Expression Vector
#292Compositions for treating pathological calcification conditions, and methods using same
#293Compositions for treating pathological calcification conditions, methods, and host cells using the same
#294Mutant Yeast Strain Capable of Degrading Cellobiose
#295Optogenetic probes for measuring membrane potential
#296Compositions for treating pathological calcification conditions, and methods using same
#297Compositions for treating pathological calcification conditions, and methods using same
#298Biopharmaceutical production method
#299Protein muNS that can form inclusions in the endoplasmic reticulum, methods for the use thereof and uses of same
#300COMPOSITIONS AND METHODS FOR PRODUCING POLYPEPTIDES WITH A MODIFIED GLYCOSYLATION PATTERN IN PLANT CELLS